Adiponectin, also known as Acrp30, is a protein hormone predominantly produced and secreted by adipocytes (fat cells). It plays a crucial role in regulating glucose levels and fatty acid breakdown. Adiponectin exists in the bloodstream in three oligomeric forms: trimer (67 kDa), hexamer (140 kDa), and high molecular weight (HMW) multimer (300 kDa) comprising at least 18 monomers .
Adiponectin is the most abundant peptide secreted by adipocytes. It has insulin-sensitizing, anti-atherogenic, and anti-inflammatory effects. The trimeric form of adiponectin, which is the focus of this article, has been shown to have significant biological activity. It can cross the blood-brain barrier and modulate neuroinflammation, making it a potential therapeutic target for neurodegenerative diseases such as Alzheimer’s .
Adiponectin plays a vital role in various metabolic processes:
Adiponectin exerts its effects through two main receptors, AdipoR1 and AdipoR2. These receptors are widely distributed in various tissues, including the liver, skeletal muscle, and vasculature. The trimeric form of adiponectin binds to these receptors, activating signaling pathways that lead to its beneficial metabolic effects .
The production and secretion of adiponectin are regulated by several factors, including:
Given its beneficial effects, adiponectin, particularly the trimeric form, has been explored as a therapeutic target for various metabolic and neurodegenerative diseases. For instance, liver-specific adiponectin gene therapy has shown promise in treating Alzheimer’s disease by reducing neuroinflammation and improving memory functions in mouse models .